Smoking and thyroid - PubMed (original) (raw)
Review
doi: 10.1111/cen.12222. Epub 2013 May 11.
Affiliations
- PMID: 23581474
- DOI: 10.1111/cen.12222
Review
Smoking and thyroid
Wilmar M Wiersinga. Clin Endocrinol (Oxf). 2013 Aug.
Abstract
Current smoking in population surveys is associated with a slight dose-dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3 induced by activation of the sympathetic nervous system; it is independent of iodine intake. In contrast, the slightly greater thyroid size in smokers is observed in iodine-deficient but not in iodine-sufficient areas and caused by competitive inhibition of thyroidal iodide uptake by thiocyanate. Smokers have an increased prevalence of nontoxic goitre and thyroid multinodularity, at least in iodine-deficient areas. Current smoking reduces dose dependently the risk of thyroid cancer, which is more pronounced for papillary than for follicular types; the risk in former smokers approaches that of never smokers. The lower TSH and lower body mass index in smokers might contribute to this reduced risk. Current smoking lowers the risk of developing thyroid peroxidase and thyroglobulin antibodies and subclinical and overt autoimmune hypothyroidism; the effect is dose dependent, but disappears within 3 years after quitting smoking. There is evidence from an animal model of experimental autoimmune thyroiditis that anti-inflammatory effects of nicotine are involved. In contrast, smoking is a dose-dependent risk factor for Graves' hyperthyroidism and especially for Graves' ophthalmopathy. Smoking is related to a higher recurrence rate of Graves' hyperthyroidism, a higher risk on Graves' ophthalmopathy after 131I therapy and a less favourable outcome of GO treatment with steroids or retrobulbar irradiation. The observed associations with smoking likely indicate causal relationships in view of consistent associations across studies, the presence of dose-response effects and disappearance of associations after cessation of smoking.
© 2013 John Wiley & Sons Ltd.
Similar articles
- Influence of cigarette smoking on thyroid gland--an update.
Sawicka-Gutaj N, Gutaj P, Sowiński J, Wender-Ożegowska E, Czarnywojtek A, Brązert J, Ruchała M. Sawicka-Gutaj N, et al. Endokrynol Pol. 2014;65(1):54-62. doi: 10.5603/EP.2014.0008. Endokrynol Pol. 2014. PMID: 24549603 Review. - [Cigarette smoking and the thyroid gland].
Bertelsen JB, Hegedüs. Bertelsen JB, et al. Ugeskr Laeger. 1995 Jul 10;157(28):4019-22. Ugeskr Laeger. 1995. PMID: 7645076 Review. Danish. - Thyroid diseases after treatment of Hodgkin's disease.
Hancock SL, Cox RS, McDougall IR. Hancock SL, et al. N Engl J Med. 1991 Aug 29;325(9):599-605. doi: 10.1056/NEJM199108293250902. N Engl J Med. 1991. PMID: 1861693 - Smoking and thyroid disorders--a meta-analysis.
Vestergaard P. Vestergaard P. Eur J Endocrinol. 2002 Feb;146(2):153-61. doi: 10.1530/eje.0.1460153. Eur J Endocrinol. 2002. PMID: 11834423 - Radiotherapy-induced thyroid disorders.
Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R. Jereczek-Fossa BA, et al. Cancer Treat Rev. 2004 Jun;30(4):369-84. doi: 10.1016/j.ctrv.2003.12.003. Cancer Treat Rev. 2004. PMID: 15145511 Review.
Cited by
- Trends of Pathological Findings in Patients with Thyroid Diseases: A Single-center, Retrospective Study.
Naseem M, Ali S, Qadir S, Riaz A, Monawwer A, Tahir B, Naseem Z, Mehmood Z. Naseem M, et al. Clin Med Insights Endocrinol Diabetes. 2024 Nov 9;17:11795514241299709. doi: 10.1177/11795514241299709. eCollection 2024. Clin Med Insights Endocrinol Diabetes. 2024. PMID: 39525566 Free PMC article. - Public Awareness of the Symptoms and Risk Factors of Thyroid Disease in Saudi Arabia.
Agwa RH, Othman W, Alkhalifah KM, Alharthi RM, Algafli FH, Alghamdi SM, Alghamdi TS, Alghamdi SI, Alharthi SJ. Agwa RH, et al. Cureus. 2024 Oct 11;16(10):e71256. doi: 10.7759/cureus.71256. eCollection 2024 Oct. Cureus. 2024. PMID: 39525262 Free PMC article. - Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal.
Li X, Song Z, Chen Y, Wu J, Jiang D, Zhang Z, Wang Z, Zhao R. Li X, et al. Cancer Immunol Immunother. 2024 Nov 2;74(1):2. doi: 10.1007/s00262-024-03816-0. Cancer Immunol Immunother. 2024. PMID: 39487885 Free PMC article. - Comparison of Thyroid Size-Specific Radioiodine Dose and New Modified Dose Calculation in the Treatment of Graves' Disease.
Wongsuttilert A, Thamcharoen R, Maiprasert Y, Siriwong S. Wongsuttilert A, et al. Endocrinol Metab (Seoul). 2024 Oct;39(5):758-766. doi: 10.3803/EnM.2024.1950. Epub 2024 Oct 14. Endocrinol Metab (Seoul). 2024. PMID: 39397513 Free PMC article. - The Impact of Environmental Factors on the Development of Autoimmune Thyroiditis-Review.
Cyna W, Wojciechowska A, Szybiak-Skora W, Lacka K. Cyna W, et al. Biomedicines. 2024 Aug 7;12(8):1788. doi: 10.3390/biomedicines12081788. Biomedicines. 2024. PMID: 39200253 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical